The forecast for female breast malignant neoplasms mortality in the US remains stable from 2024 to 2028, with values around 25 deaths per 100,000 women. For context, in 2023, the figure stood at 25.3. Thus, there is a slight decrease when comparing 2023 to the forecasted period up to 2028, showing a gradual improvement in mortality rates.
Year-on-year variations indicate stability with marginal improvements; a minor decline is observed between 2026 and 2027. When considering a broader view, there's a small decrease over the last five years (including forecast), suggesting a slight negative CAGR.
Future trends to watch for:
- Advancements in medical treatments and technologies, potentially reducing mortality rates further.
- Public health initiatives aimed at early detection and prevention, influencing future forecasts positively.
- Population dynamics and demographic changes impacting overall mortality statistics.
